Stage IV Fallopian Tube Cancer (DBCOND0030572)

Identifiers

Synonyms

Fallopian tube cancer stage IV / Malignant neoplasm of fallopian tube metastatic / Fallopian tube cancer metastatic / Malignant neoplasm of fallopian tube stage IV

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Bevacizumab	A monoclonal anti-vascular endothelial growth factor antibody used in combination with antineoplastic agents for the treatment of many types of cancer.	Vascular endothelial growth factor A, long formtarget Complement C1q subcomponent subunit Atarget Complement C1q subcomponent subunit Btarget Complement C1q subcomponent subunit Ctarget Low affinity immunoglobulin gamma Fc region receptor III-Atarget Low affinity immunoglobulin gamma Fc region receptor II-atarget Low affinity immunoglobulin gamma Fc region receptor II-btarget Low affinity immunoglobulin gamma Fc region receptor II-ctarget High affinity immunoglobulin gamma Fc receptor Itarget

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT04701645	Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer	No drug interventions	diagnostic	1	recruiting
NCT06290193	Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Primary Cytoreductive Surgery	No drug interventions	treatment	2	recruiting
NCT03922776	Phenotypic Characterization Tumor-infiltrating Lymphocytes at Diagnosis and After Chemotherapy in Ovarian Cancer	No drug interventions	other	Not Available	active_not_recruiting
NCT01982487	Vaccine Therapy and IDO1 Inhibitor INCB024360 in Treating Patients With Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Are in Remission	Epacadostat vCP2292	treatment	1 / 2	withdrawn
NCT00899093	YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy	No drug interventions	Not Available	Not Available	terminated
NCT03188432	Hyperthermic Intraperitoneal Chemotherapy Trial Comparing Quality of Life in Patients With Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	Carboplatin	treatment	2	completed
NCT02470559	Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent	Aldesleukin Muromonab Sargramostim	treatment	1	withdrawn
NCT04267575	Canady Helios Cold Plasma Scalpel Treatment at the Surgical Margin and Macroscopic Tumor Sites	No drug interventions	treatment	Not Available	unknown_status
NCT02872519	PET Imaging of Ovarian Carcinoma With 18F-FSPG	No drug interventions	diagnostic	0	withdrawn
NCT01606241	Vaccine Therapy and Cyclophosphamide in Treating Patients With Stage II-III Breast or Stage II-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer	Benzalkonium Cyclophosphamide Folic acid	treatment	1	completed
NCT01010126	Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer	Bevacizumab Menthol Sirolimus Temsirolimus	treatment	2	completed
NCT05659381	Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer	Cisplatin	treatment	3	recruiting
NCT01175343	RO4929097 in Treating Patients With Recurrent and/or Metastatic Epithelial Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer	RG-4733	treatment	2	completed
NCT01275664	Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer	Aprepitant Carboplatin Chloride ion Cisplatin Dexamethasone Granisetron Platinum	supportive_care	Not Available	terminated
NCT01536054	Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer	Sargramostim Sirolimus vCP2292	treatment	1	completed
NCT00262847	Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer	Bevacizumab Carboplatin Paclitaxel	treatment	3	completed
NCT00857545	OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission	Adagloxad simolenin Polyvalent antigen-KLH conjugate vaccine	treatment	2	completed
NCT03029611	IGFBP-2 Vaccine and Combination Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Undergoing Surgery	Carboplatin Paclitaxel	treatment	2	terminated
NCT02311907	Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer	Carboplatin Glutathione Paclitaxel	supportive_care	3	completed
NCT02122185	Metformin and Chemotherapy in Treating Patients With Stage III-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	Metformin	treatment	2	active_not_recruiting
NCT00388037	Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer	Sunitinib	treatment	2	completed
NCT05429970	A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)	Etodolac Propranolol	prevention	Not Available	recruiting
NCT00897442	Collecting Tumor Samples From Patients With Gynecological Tumors	No drug interventions	Not Available	Not Available	completed
NCT02833506	Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer	Baloramotide Sirolimus	treatment	1	withdrawn
NCT02111941	Vaccine Therapy for Patients With Stage IIIC-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer	Folic acid	treatment	0	active_not_recruiting
NCT04811703	Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Associated With Systemic Chemotherapy in Women With Advanced Ovarian Cancer	No drug interventions	treatment	1	recruiting
NCT01080521	Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy	No drug interventions	Not Available	Not Available	completed